Active Ingredients, Intermediates and Compounds

Latest White Papers

AqVida - Active Pharmaceutical Ingredients List

Abstract
AqVida offers a range of high-quality active pharmaceutical ingredients. Download this free white paper to see AqVida's portfolio of products.

Company

AqVida

Biocompatible PC Technology™ Coatings for Drug...

Abstract
PC Technology™ comprises a family of synthetic hydrogel polymers, which are used as coatings to improve the biocompatibility of medical devices,...

Company

Vertellus Biomaterials

Temperature & Time Relationship

The lag time between a sample of approx 400ml and air at 8°C has been established at in excess of 60 minutes. If monitoring systems are set to alarm on product temperature a considerable window of opportunity to take corrective action has been

Biostore UK

Process Development and Pilot Production of Advanced Stage Intermediates and APIs

Niels Clauson-Kaas (NCK) serves the global life science industry in the field of organic chemistry R&D on a contract basis, with a stringent focus on process development and pilot production of advanced stage intermediates and active pharmaceutical ingredients

Niels Clauson-Kaas (NCK)

Linking Biological Molecules to Highly Potent APIs

Medical researchers are arming themselves with a new series of weapons in the war against disease – conjugated drugs that link biological molecules to a highly potent active pharmaceutical ingredient (HPAPIs). To find out more, download this

SAFC Pharma

TAPI (Teva Active Pharmaceutical Ingredients) – API Product List

TAPI (Teva Active Pharmaceutical Ingredients) is one of the leading global suppliers of active pharmaceutical ingredients. With a portfolio of over 290 APIs, TAPI offers excellent customer service, solid-state expertise and an extensive IP portfolio

TAPI (Teva Active Pharmaceutical Ingredients)

Product Lifecycle Management - Maximizing Profit and Leveraging Innovation

The cost of developing a new drug is continuously rising. Many other factors, such as stricter regulations and stronger global competition, are also creating major challenges. If a pharmaceutical company intends to increase its market share and return

Vetter Pharma International

Vetter Case Study - Speeding Up Time to Market

In the hyper-competitive pharmaceuticals and biotechnology markets, companies face a litany of challenges, from stricter regulatory guidelines and rising development costs to the pressures of globalization. To succeed under these conditions, pharmaceuticals

Vetter Pharma International

Lifeline Industries: Active Pharmaceutical Ingredients, Intermediates and Reaction Capabilities

Lifeline Industries, a pharmaceutical manufacturer represented by Euro Pharma, has recently started production of a range of new APIs. The company also manufactures intermediates, and has an impressive range of reaction capabilities. All of Lifeline

Euro Pharma

ENAMINE Libraries for Fragment-Based Drug Discovery

The Fragment-Based Approach to Drug Discovery (FBDD) has been established as an efficient tool in the search for new drugs. Understanding the increasing importance of the FBDD for modern pharmaceutical industry, we set a goal to design a

Enamine Ltd

Submit white papers to proactively position your company as a key solution provider and create interest among buyers.

Email: pharmaceuticalsales@nridigital.com
Telephone: +44 (0) 207 915 9957